A Study of Sonrotoclax Combined With Glofitamab and GemOx for Relapsed or Refractory Large B-Cell Lymphoma (ChiCTR) - Sep 16, 2026 - P2 | N=39 | Not yet recruiting | Sponsor: The First Affiliated Hospital of Soochow University; The First Affiliated Hospital of Soochow University
New P2 trial • B Cell Lymphoma • Diffuse Large B Cell Lymphoma • Hematological Malignancies • High-grade B-cell lymphoma • Indolent Lymphoma • Large B Cell Lymphoma • Lymphoma • Non-Hodgkin's Lymphoma • Oncology • BCL2 • BCL6
|